{"organizations": [], "uuid": "021250c7b399305f2c8e776f0408d44acd32082a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-teva-canada-announces-launch-of-ge/brief-teva-canada-announces-launch-of-generic-concerta-for-treatment-of-adhd-idUSASC09TBJ", "country": "US", "domain_rank": 408, "title": "BRIEF-Teva Canada Announces Launch Of Generic Concerta For Treatment Of ADHD", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-22T14:22:00.000+02:00", "replies_count": 0, "uuid": "021250c7b399305f2c8e776f0408d44acd32082a"}, "author": "", "url": "https://www.reuters.com/article/brief-teva-canada-announces-launch-of-ge/brief-teva-canada-announces-launch-of-generic-concerta-for-treatment-of-adhd-idUSASC09TBJ", "ord_in_thread": 0, "title": "BRIEF-Teva Canada Announces Launch Of Generic Concerta For Treatment Of ADHD", "locations": [], "entities": {"persons": [], "locations": [{"name": "canada", "sentiment": "none"}], "organizations": [{"name": "brief-teva canada announces launch of generic conc", "sentiment": "negative"}, {"name": "brief-teva canada announces launch of generic concerta", "sentiment": "negative"}, {"name": "treatment of adhd reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "teva pharmaceutical industries ltd", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 22, 2018 / 12:23 PM / Updated 8 minutes ago BRIEF-Teva Canada Announces Launch Of Generic Concerta For Treatment Of ADHD Reuters Staff March 22 (Reuters) - Teva Pharmaceutical Industries Ltd: * ACT METHYLPHENIDATE ER® TABLETS, A GENERIC VERSION OF CONCERTA® FOR THE TREATMENT OF ADHD * TEVA CANADA LIMITED SAYS HEALTH CANADA APPROVED ITS APPLICATION FOR (C)ACT METHYLPHENIDATE ER TABLETS Source text for Eikon:", "external_links": [], "published": "2018-03-22T14:22:00.000+02:00", "crawled": "2018-03-22T14:34:06.010+02:00", "highlightTitle": ""}